Xiao Luo Selected Research

quinocetone

11/2015	Roles of ROS mediated oxidative stress and DNA damage in 3-methyl-2-quinoxalin benzenevinylketo-1, 4-dioxide-induced immunotoxicity of Sprague-Dawley rats.
2/2012	Pu-erh black tea extract supplementation attenuates the oxidative DNA damage and oxidative stress in Sprague-Dawley rats with renal dysfunction induced by subchronic 3-methyl-2-quinoxalin benzenevinylketo-1,4-dioxide exposure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao Luo Research Topics

Disease

34	Neoplasms (Cancer) 10/2022 - 01/2011
10	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2017
9	Inflammation (Inflammations) 10/2022 - 11/2009
9	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2016
6	Cognitive Dysfunction 01/2021 - 10/2016
4	Colorectal Neoplasms (Colorectal Cancer) 11/2021 - 01/2019
4	Triple Negative Breast Neoplasms 10/2021 - 01/2019
4	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2012
4	Body Weight (Weight, Body) 01/2020 - 01/2019
4	Obesity 01/2020 - 10/2014
3	Pain (Aches) 09/2021 - 01/2020
3	Dementia (Dementias) 01/2021 - 01/2019
3	Schizophrenia (Dementia Praecox) 01/2020 - 12/2014
3	Lung Neoplasms (Lung Cancer) 01/2019 - 08/2016
3	Simpson-Golabi-Behmel syndrome 01/2016 - 01/2012
2	Liver Neoplasms (Liver Cancer) 10/2022 - 01/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2022 - 05/2020
2	Carcinogenesis 05/2022 - 01/2012
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 01/2017
2	Infarction (Infarctions) 01/2022 - 11/2009
2	Hemorrhage 01/2022 - 01/2017
2	COVID-19 04/2021 - 12/2020
2	Keloid 01/2021 - 01/2021
2	Myocardial Infarction 01/2021 - 11/2009
2	Ischemia 01/2021 - 11/2009
2	Atrophy 01/2021 - 01/2017
2	Insulin Resistance 12/2020 - 04/2016
2	Hyperplasia 12/2020 - 05/2020
2	Nasopharyngeal Carcinoma 11/2020 - 05/2020
2	Reperfusion Injury 10/2020 - 11/2009
2	Thrombosis (Thrombus) 05/2020 - 09/2017
2	Non-alcoholic Fatty Liver Disease 01/2020 - 09/2019
2	Hypoxia (Hypoxemia) 09/2019 - 12/2012
2	Parkinson Disease (Parkinson's Disease) 02/2019 - 11/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2019
2	Rupture 12/2017 - 01/2017
2	Leukemia 10/2017 - 11/2016
2	Stomach Neoplasms (Stomach Cancer) 06/2016 - 01/2012
2	Dysentery 11/2015 - 02/2012
1	Gestational Diabetes (Gestational Diabetes Mellitus) 10/2022
1	Gallstones (Gallstone) 10/2022
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 10/2022
1	Lymphoma (Lymphomas) 08/2022
1	Takotsubo Cardiomyopathy 05/2022
1	Tachycardia (Tachyarrhythmias) 05/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022
1	Stroke (Strokes) 01/2022
1	Aneurysm (Aneurysms) 01/2022
1	Gastrointestinal Hemorrhage (Hematochezia) 01/2022
1	Cleft Lip (Harelip) 01/2022
1	Neuromyelitis Optica (Devic's Disease) 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Brain Edema (Cerebral Edema) 01/2022
1	Atrial Fibrillation 01/2022

Drug/Important Bio-Agent (IBA)

18	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2012
12	Proteins (Proteins, Gene)FDA Link 10/2022 - 06/2009
8	Biological ProductsIBA 05/2022 - 01/2017
7	Long Noncoding RNAIBA 10/2022 - 01/2019
6	Messenger RNA (mRNA)IBA 10/2022 - 01/2017
5	Apolipoproteins E (ApoE)IBA 01/2021 - 01/2016
4	MicroRNAs (MicroRNA)IBA 10/2022 - 01/2012
4	CollagenIBA 01/2021 - 01/2015
4	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2018
4	Pharmaceutical PreparationsIBA 01/2020 - 11/2016
3	ApolipoproteinsIBA 01/2021 - 01/2016
3	LipidsIBA 01/2021 - 01/2020
2	Neuroprotective AgentsIBA 01/2022 - 01/2017
2	Polycomb Repressive Complex 2IBA 01/2022 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 03/2021
2	CopperIBA 10/2021 - 05/2020
2	InterferonsIBA 10/2021 - 01/2011
2	VaccinesIBA 04/2021 - 12/2020
2	Sirtuin 1IBA 01/2020 - 04/2016
2	Docosahexaenoic AcidsIBA 01/2020 - 04/2016
2	disodium (R,R)- 5- (2- ((2- (3- chlorophenyl)- 2- hydroxyethyl)- amino)propyl)- 1,3- benzodioxole- 2,3- dicarboxylateIBA 12/2019 - 10/2019
2	AntioxidantsIBA 09/2019 - 01/2017
2	Therapeutic UsesIBA 06/2019 - 10/2014
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2019 - 12/2018
2	Histones (Histone)IBA 10/2017 - 01/2017
2	Lysine (L-Lysine)FDA Link 10/2017 - 01/2017
2	Transcription Factors (Transcription Factor)IBA 08/2016 - 01/2011
2	quinocetoneIBA 11/2015 - 02/2012
2	Fibroblast Growth Factor 1 (FGF-1)IBA 08/2015 - 01/2012
1	Hormones (Hormone)IBA 10/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2022
1	Troponin IIBA 05/2022
1	Competitive Endogenous RNAIBA 05/2022
1	Circular RNAIBA 05/2022
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022
1	AnticoagulantsIBA 01/2022
1	EED226IBA 01/2022
1	Vitamin K FDA Link 01/2022
1	Piwi-Interacting RNAIBA 01/2022
1	Warfarin (Coumadin)FDA LinkGeneric 01/2022

Therapy/Procedure

13	Therapeutics 01/2022 - 11/2009
8	Drug Therapy (Chemotherapy) 08/2022 - 12/2012
2	Injections 08/2021 - 01/2020
2	Precision Medicine 01/2020 - 04/2019
1	Cholecystectomy 10/2022
1	Ventriculoperitoneal Shunt 01/2022